Richard A Hotchkiss

Title: The Innovative Contributions of Richard A. Hotchkiss

Introduction

Richard A. Hotchkiss is a notable inventor based in Chesterfield, MO (US). He has made significant strides in the field of pharmaceutical innovations, particularly in targeted therapeutic delivery systems. His work focuses on developing compounds that can effectively treat cancer by selectively inducing apoptosis in cancer cells.

Latest Patents

Hotchkiss holds a patent for a "Modular platform for targeted therapeutic delivery." This patent discloses pharmaceutical compounds, compositions, and methods of treatment that involve a targeting moiety capable of binding to cell receptors with a high affinity. The targeting moiety is designed to be covalently attached to a pharmaceutically active moiety, which is a pro-apoptotic peptide. The methods outlined in the patent include administering these compounds to subjects in need, with the potential for co-administration of radiation therapy or additional chemotherapeutic agents.

Career Highlights

Richard A. Hotchkiss is affiliated with Washington University, where he contributes to research and development in the pharmaceutical field. His innovative approach to cancer treatment has garnered attention and recognition within the scientific community.

Collaborations

Hotchkiss has collaborated with esteemed colleagues such as Jonathan E. McDunn and William G. Hawkins. Their combined expertise enhances the research efforts and the development of effective therapeutic solutions.

Conclusion

Richard A. Hotchkiss exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in targeted cancer therapies, highlight the importance of research and collaboration in advancing medical science.